SCHEMBL13720643

SCHEMBL13720643

Cc1cccc(Oc2ccc(NC(=O)[C@@H](C)N(C(=O)O)C(C)(C)C)cn2)c1C.Cc1cccc(Oc2ccc(NC(=O)[C@@H](C)N)cn2)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.43
LMNA P02545 1/20 0.41
ALDH1A1 P00352 2/20 0.38
POLB P06746 2/20 0.38
KMT2A Q03164 1/20 0.38
HTR2C P28335 3/20 0.38
XIAP P98170 1/20 0.37
TAAR1 Q96RJ0 1/20 0.36
LTA4H P09960 2/20 0.36
GAA P10253 2/20 0.36
CRHBP P24387 1/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
CRHR2 Q13324 1/20 0.36
RAB9A P51151 1/20 0.35
PKM P14618 1/20 0.35
GABRA5 P31644 1/20 0.35
NOTUM Q6P988 1/20 0.34
CASP1 P29466 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13721319 0.95 KEAP1 (0.45) KEAP1LMNAALDH1A1POLBKMT2A
SCHEMBL1979857 0.87 KEAP1 (0.55) KEAP1LMNAALDH1A1POLBKMT2A
SCHEMBL21980941 0.87 KMT2A (0.47) ALDH1A1POLBKMT2AHTR2CGAA
SCHEMBL13720953 0.87 KMT2A (0.47) ALDH1A1POLBKMT2AHTR2CGAA
SCHEMBL13720692 0.86 ALDH1A1 (0.37) LMNAALDH1A1POLBKMT2AHTR2C
SCHEMBL21980939 0.86 KMT2A (0.42) ALDH1A1POLBKMT2AHTR2CLTA4H
SCHEMBL13721302 0.86 KMT2A (0.42) ALDH1A1POLBKMT2AHTR2CLTA4H
SCHEMBL13721813 0.82 GAA (0.42) ALDH1A1POLBKMT2AXIAPLTA4H
SCHEMBL13721340 0.81 ALDH1A1 (0.40) LMNAALDH1A1POLBKMT2AHTR2C
SCHEMBL13720879 0.80 KMT2A (0.43) LMNAALDH1A1POLBKMT2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160058737-A1 IMIDAZOLIDINEDIONE DERIVATIVES AUTIFONY THERAPEUTICS LIMITED (GB) 2016-03-03 US disclosed
US-8722695-B2 Imidazolidinedione derivatives AUTIFONY THERAPEUTICS LIMITED (GB) 2014-05-13 US disclosed
US-20120289526-A1 IMIDAZOLIDINEDIONE DERIVATIVES AUTIFONY THERAPEUTICS LIMITED (GB) 2012-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160058737-A1 IMIDAZOLIDINEDIONE DERIVATIVES KCND3, KCNK3, KCNA3 KEAP1 3193/4885LMNA 2187/4885ALDH1A1 848/4885
US-20120289526-A1 IMIDAZOLIDINEDIONE DERIVATIVES KCND3, KCNK3, KCNA3 KEAP1 2956/4885LMNA 2517/4885ALDH1A1 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.